Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 1, 1999, Pages 16-20

  Tizzani, A ^a   Gontero, P ^b   Casetta, G ^a   Piana, P ^a   Baima, C ^a   De Zan, A ^a   Bodo, G ^a   Pacchioni, D ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Immunohistochemistry; Neuronal damage; Prostate electrovaporization; Safety; Side effects

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DYSURIA; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SAFETY; TECHNIQUE; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION;

EID: 0032974390     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500268     Document Type: Article

References (28)

1. Neal DE. The morbidity of transurethral resection of the prostate. Clin Op Urol 1996; 6: 147-150.
2. Fowler FJ Jr et al. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018-3022.
3. Wennberg JE et al. An assessment of prostatectomy for benign urinary tract obstruction. JAMA 1988; 259: 3027-3030.
4. Thorpe AC et al. Deaths and complications following prostatectomy in 1400 men in the northern region. Br J Urol 1994; 74: 559-565.
5. Olsson J, Nlsson A, Hahn RG. Symptom of the transurethral resection syndrome using glycine as the irrigant. J Urol 1995; 154: 123-128.
6. Mebust WK et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-247.
7. Ekengren J, Hahn RG. Complications during transurethral vaporization of the prostate. Urology 1996; 48: 424-427.
8. Larson TR, Religo WM, Collins JM, Novieki D. Detailed prostatic interstitial thermal mapping during transurethral grooved roller-ball electrovaporization and loop electrosurgery for benign prostatic hyperplasia. Urology 1996; 48: 501-507.
9. Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995; 45: 566-572.
10. Kaplan SA, Santarosa RP, Te AE. Electrovaporization of the prostate for symptomatic benign prostatic hyperplasia: the 1 year experience (Abstract). J Urol 1996; 155: 405A.
11. Hamawy KJ, Siroky MB, Krane RJ, Babayan RK. Transurethral vaporization of the prostate (TUVP): an electrosurgical alternative for BPH (abstract). J Endourol 1995; 9 (Suppl 1): 5124.
12. Catalona W et al. Increased specificity of PSA screening through measurement of percentage free PSA in serum. J Urol 1995; 153: 312A, Abstract 336.
13. Kindblam LG et al. S-100 protein in melanocytic tumours. Acta Path Microbiol Immunol Scand. Sect A 1984; 92: 219-230.
14. Miettinen M, Lehto VP, Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumours. Ultrastruct Pathol 1984; 7: 83-107.
15. Narayan P et al. Transurethral vaportrode electrovaporization of the prostate: physical principles, technique and results. Urology 1996; 47: 505-510.
16. Patel A, Fuchs GJ. Basic principles, discussion of variables and operative techniques of TUEVP. Urotrends 1996; 1: 1-8.
17. Piana P, Giammo' A, De Zan A, Tizzani A. Biophysical principles of tissue vaporization. Min Urol Nephrol 1997; 49: 151-156.
18. Hamawy KJ et al. Transurethral vaporization of the prostate (TUVP): clinical follow-up at one year (Abstract). J Urol 1996 Suppl; 155: 404A.
19. Gallucci M et al. Transurethral electrovaporizaton of the prostate (T.V.P.) vs TURP: A multicentric randomized comparative study (Abstract). Eur Urol 1996; 30: 398.
20. Evans RM, Bernhard PH, Reddy PK. A randomized study of transurethral resection of the prostate gland and transurethral vaporization of the prostate gland. (Abstract). J Urol 1997; 157 (Suppl): 556.
21. Narayan, P et al. Factors affecting size and configuration of electrovaporization lesions in the prostate. Urology 1995; 47: 679-688.
22. Larson TR, Religo WM, Collins JM, Novicki D. Detailed prostatic interstitial thermal mapping during transurethral grooved roller-ball electrovaporization and loop electrosurgery for benign prostatic hyperplasia. Urology 1996; 48: 501-507.
23. Reis RB et al. Interstitial thermometry in men undergoing electrovaporization: is it safe? (Abstract). J Urol 1996; 155 (Suppl) 707A, 1585.
24. Permutter AP, Muschter R, Rarvi HA. Electrosurgical vaporization of the prostate in the canine model. Urology 1995; 46: 518-526.
25. Perachino M et al. Does transurethral thermotherapy induce a long-term alpha blockade? Eur Urol 1993; 23: 299-301.
26. Kabalin JN. Laser prostatectomy performed with a right angle firing neodynium: YAG laser fiber at 40W power setting. J Urol 1993; 150: 95-99.
27. De la Rosette JJMCH et al. High energy thermotherapy in treatment of benign prostatic hyperplasia: results of European Benign Prostatic Hyperplasia Study Group. J Urol 1996; 156: 97-102.
28. Kaplan SA. Electrovaporization of the prostate. Durable modality or passing fad? Urology 1997; 49: 157-159.